A citation-based method for searching scientific literature

Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor, Christina A Meyers. Lancet Oncol 2009
Times Cited: 1422







List of co-cited articles
655 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Paul D Brown, Kurt Jaeckle, Karla V Ballman, Elana Farace, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Fred G Barker, Richard Deming, Stuart H Burri,[...]. JAMA 2016
653
51

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, Salvador Villà, Francois Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2011
42

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
Hidefumi Aoyama, Hiroki Shirato, Masao Tago, Keiichi Nakagawa, Tatsuya Toyoda, Kazuo Hatano, Masahiro Kenjyo, Natsuo Oya, Saeko Hirota, Hiroki Shioura,[...]. JAMA 2006
42

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Paul D Brown, Karla V Ballman, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Anthony C Whitton, Jeffrey Greenspoon, Ian F Parney, Nadia N I Laack, Jonathan B Ashman,[...]. Lancet Oncol 2017
387
36

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
Masaaki Yamamoto, Toru Serizawa, Takashi Shuto, Atsuya Akabane, Yoshinori Higuchi, Jun Kawagishi, Kazuhiro Yamanaka, Yasunori Sato, Hidefumi Jokura, Shoji Yomo,[...]. Lancet Oncol 2014
634
28

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
R A Patchell, P A Tibbs, W F Regine, R J Dempsey, M Mohiuddin, R J Kryscio, W R Markesbery, K A Foon, B Young. JAMA 1998
24

A randomized trial of surgery in the treatment of single metastases to the brain.
R A Patchell, P A Tibbs, J W Walsh, R J Dempsey, Y Maruyama, R J Kryscio, W R Markesbery, J S Macdonald, B Young. N Engl J Med 1990
24

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
David W Andrews, Charles B Scott, Paul W Sperduto, Adam E Flanders, Laurie E Gaspar, Michael C Schell, Maria Werner-Wasik, William Demas, Janice Ryu, Jean-Paul Bahary,[...]. Lancet 2004
24

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D Brown, Vinai Gondi, Stephanie Pugh, Wolfgang A Tome, Jeffrey S Wefel, Terri S Armstrong, Joseph A Bovi, Cliff Robinson, Andre Konski, Deepak Khuntia,[...]. J Clin Oncol 2020
146
22

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Paul W Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K Sneed, Samuel T Chao, Robert J Weil, John Suh,[...]. J Clin Oncol 2012
804
21

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, W G McKenna, R Byhardt. Int J Radiat Oncol Biol Phys 1997
19

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, Jeffrey S Weinberg, Jing Li, Paul Brown, Stephen Settle, Sujit S Prabhu, Frederick F Lang, Nicholas Levine,[...]. Lancet Oncol 2017
242
18

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E Gaspar, Steve Braunstein,[...]. JAMA Oncol 2017
264
18


Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Vinai Gondi, Stephanie L Pugh, Wolfgang A Tome, Chip Caine, Ben Corn, Andrew Kanner, Howard Rowley, Vijayananda Kundapur, Albert DeNittis, Jeffrey N Greenspoon,[...]. J Clin Oncol 2014
541
17

Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Jill S Barnholtz-Sloan, Andrew E Sloan, Faith G Davis, Fawn D Vigneau, Ping Lai, Raymond E Sawaya. J Clin Oncol 2004
880
16

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Hussein A Tawbi, Peter A Forsyth, Alain Algazi, Omid Hamid, F Stephen Hodi, Stergios J Moschos, Nikhil I Khushalani, Karl Lewis, Christopher D Lao, Michael A Postow,[...]. N Engl J Med 2018
477
15

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Riccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, Salvador Villa, François Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2013
393
15

Epidemiology of brain metastases.
Lakshmi Nayak, Eudocia Quant Lee, Patrick Y Wen. Curr Oncol Rep 2012
511
15

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.
E Shaw, C Scott, L Souhami, R Dinapoli, R Kline, J Loeffler, N Farnan. Int J Radiat Oncol Biol Phys 2000
956
13

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Paul D Brown, Stephanie Pugh, Nadia N Laack, Jeffrey S Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H Suh, David Roberge,[...]. Neuro Oncol 2013
431
12

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
Paul W Sperduto, Samuel T Chao, Penny K Sneed, Xianghua Luo, John Suh, David Roberge, Amit Bhatt, Ashley W Jensen, Paul D Brown, Helen Shih,[...]. Int J Radiat Oncol Biol Phys 2010
614
12

Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis.
Arjun Sahgal, Hidefumi Aoyama, Martin Kocher, Binod Neupane, Sandra Collette, Masao Tago, Prakesh Shaw, Joseph Beyene, Eric L Chang. Int J Radiat Oncol Biol Phys 2015
255
12

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
Paul W Sperduto, Brian Berkey, Laurie E Gaspar, Minesh Mehta, Walter Curran. Int J Radiat Oncol Biol Phys 2008
609
12

Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.
Eric J Lehrer, Jennifer L Peterson, Nicholas G Zaorsky, Paul D Brown, Arjun Sahgal, Veronica L Chiang, Samuel T Chao, Jason P Sheehan, Daniel M Trifiletti. Int J Radiat Oncol Biol Phys 2019
55
20

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Scott N Gettinger, Amit Mahajan, Anne C Chiang, Roy S Herbst, Mario Sznol, Apostolos John Tsiouris, Justine Cohen, Alexander Vortmeyer, Lucia Jilaveanu,[...]. Lancet Oncol 2016
555
11

Response assessment criteria for brain metastases: proposal from the RANO group.
Nancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, Igor J Barani, Daniel P Barboriak, Brigitta G Baumert, Martin Bendszus, Paul D Brown, D Ross Camidge, Susan M Chang,[...]. Lancet Oncol 2015
342
11

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
Giuseppe Minniti, Enrico Clarke, Gaetano Lanzetta, Mattia Falchetto Osti, Guido Trasimeni, Alessandro Bozzao, Andrea Romano, Riccardo Maurizi Enrici. Radiat Oncol 2011
373
11

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
Riccardo Soffietti, Ufuk Abacioglu, Brigitta Baumert, Stephanie E Combs, Sara Kinhult, Johan M Kros, Christine Marosi, Philippe Metellus, Alexander Radbruch, Salvador S Villa Freixa,[...]. Neuro Oncol 2017
177
11

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Georgina V Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander D Guminski, Michael P Brown, James S Wilmott, Jarem Edwards, Maria Gonzalez, Richard A Scolyer,[...]. Lancet Oncol 2018
377
11

Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
Giuseppe Minniti, Claudia Scaringi, Sergio Paolini, Gaetano Lanzetta, Andrea Romano, Francesco Cicone, Mattia Osti, Riccardo Maurizi Enrici, Vincenzo Esposito. Int J Radiat Oncol Biol Phys 2016
151
10

Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
Eric J Lehrer, Jennifer Peterson, Paul D Brown, Jason P Sheehan, Alfredo Quiñones-Hinojosa, Nicholas G Zaorsky, Daniel M Trifiletti. Radiother Oncol 2019
83
10

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
Paul W Sperduto, Wen Jiang, Paul D Brown, Steve Braunstein, Penny Sneed, Daniel A Wattson, Helen A Shih, Ananta Bangdiwala, Ryan Shanley, Natalie A Lockney,[...]. Int J Radiat Oncol Biol Phys 2017
89
10

Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: Results from a randomized trial.
Lucyna Kępka, Dobromira Tyc-Szczepaniak, Krzysztof Bujko, Marta Olszyna-Serementa, Wojciech Michalski, Arkadiusz Sprawka, Berenika Trąbska-Kluch, Katarzyna Komosińska, Ewa Wasilewska-Teśluk, Beata Czeremszyńska. Radiother Oncol 2016
35
22

Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
Takamasa Kayama, Shinya Sato, Kaori Sakurada, Junki Mizusawa, Ryo Nishikawa, Yoshitaka Narita, Minako Sumi, Yasuji Miyakita, Toshihiro Kumabe, Yukihiko Sonoda,[...]. J Clin Oncol 2018
41
19

A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores.
Masaaki Yamamoto, Toru Serizawa, Yoshinori Higuchi, Yasunori Sato, Jun Kawagishi, Kazuhiro Yamanaka, Takashi Shuto, Atsuya Akabane, Hidefumi Jokura, Shoji Yomo,[...]. Int J Radiat Oncol Biol Phys 2017
87
9

Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Penny K Sneed, Joe Mendez, Johanna G M Vemer-van den Hoek, Zachary A Seymour, Lijun Ma, Annette M Molinaro, Shannon E Fogh, Jean L Nakamura, Michael W McDermott. J Neurosurg 2015
133
8

Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Kirtesh R Patel, Stuart H Burri, Anthony L Asher, Ian R Crocker, Robert W Fraser, Chao Zhang, Zhengjia Chen, Shravan Kandula, Jim Zhong, Robert H Press,[...]. Neurosurgery 2016
78
10

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?
C J Vecht, H Haaxma-Reiche, E M Noordijk, G W Padberg, J H Voormolen, F H Hoekstra, J T Tans, N Lambooij, J A Metsaars, A R Wattendorff. Ann Neurol 1993
681
8

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, Xiaobu Ye, Ariel E Marciscano, Patrick M Forde, Julie Brahmer, Evan Lipson, William Sharfman, Hans Hammers,[...]. Int J Radiat Oncol Biol Phys 2018
116
7

Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.
Allison M Martin, Daniel N Cagney, Paul J Catalano, Brian M Alexander, Amanda J Redig, Jon D Schoenfeld, Ayal A Aizer. JAMA Oncol 2018
101
7

Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
Giuseppe Minniti, Vincenzo Esposito, Enrico Clarke, Claudia Scaringi, Gaetano Lanzetta, Maurizio Salvati, Antonino Raco, Alessandro Bozzao, Riccardo Maurizi Enrici. Int J Radiat Oncol Biol Phys 2013
112
7

Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin.
Michael A Vogelbaum, Lilyana Angelov, Shih-Yuan Lee, Liang Li, Gene H Barnett, John H Suh. J Neurosurg 2006
143
7

A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
Cameron Brennan, T Jonathan Yang, Patrick Hilden, Zhigang Zhang, Kelvin Chan, Yoshiya Yamada, Timothy A Chan, Stella C Lymberis, Ashwatha Narayana, Viviane Tabar,[...]. Int J Radiat Oncol Biol Phys 2014
128
7

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Michael A Davies, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Keith T Flaherty, Ana Arance, Vanna Chiarion-Sileni, Luc Thomas, Thierry Lesimple, Laurent Mortier,[...]. Lancet Oncol 2017
275
7

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.
May N Tsao, Dirk Rades, Andrew Wirth, Simon S Lo, Brita L Danielson, Laurie E Gaspar, Paul W Sperduto, Michael A Vogelbaum, Jeffrey D Radawski, Jian Z Wang,[...]. Pract Radiat Oncol 2012
366
7

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
Kim Margolin, Marc S Ernstoff, Omid Hamid, Donald Lawrence, David McDermott, Igor Puzanov, Jedd D Wolchok, Joseph I Clark, Mario Sznol, Theodore F Logan,[...]. Lancet Oncol 2012
705
7

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
William J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, T Jonathan Yang, Natalie A Lockney, Naamit K Gerber, Kathryn Beal, Arya Amini, Tejas Patil, Brian D Kavanagh,[...]. J Clin Oncol 2017
197
7

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
6

Brain metastases: epidemiology and pathophysiology.
Igor T Gavrilovic, Jerome B Posner. J Neurooncol 2005
519
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.